These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prostate-specific antigen as a prognostic parameter of treated prostate carcinoma--a reliable tumor marker?]. Knönagel H; Gautschi K; Vonderschmitt DJ; Hauri D Helv Chir Acta; 1988 Jul; 55(3):333-5. PubMed ID: 2459081 [No Abstract] [Full Text] [Related]
3. [Value of the search for specific prostatic antigens in fixed specimens]. Stouffs M; Wilmus JP; Couvreur Y; Dossogne M Acta Urol Belg; 1984; 52(4):588-92. PubMed ID: 6083718 [No Abstract] [Full Text] [Related]
4. [Value of the immunohistochemical detection of PSA in the diagnosis of carcinoma of the prostate]. Escaf S; Isorna S; Riesgo I Arch Esp Urol; 1987; 40(9):627-31. PubMed ID: 2449870 [No Abstract] [Full Text] [Related]
5. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen. Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202 [TBL] [Abstract][Full Text] [Related]
6. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364 [TBL] [Abstract][Full Text] [Related]
11. Requirements for an idealized animal model of prostatic cancer. Coffey DS; Isaacs JT Prog Clin Biol Res; 1980; 37():379-91. PubMed ID: 7384094 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical markers for prostatic cancer. Nadji M; Morales AR Ann N Y Acad Sci; 1983; 420():134-9. PubMed ID: 6586093 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of cancer of the prostate]. Perrin P Presse Med; 1992 Jan; 21(3):105-7. PubMed ID: 1372123 [No Abstract] [Full Text] [Related]
14. [Prostate-specific antigen in the diagnosis of prostatic carcinoma]. Virseda JA; Morente M; Piris MA; Melchor AM; Gil Pascual B; Gómez A Actas Urol Esp; 1985; 9(1):89-94. PubMed ID: 2409752 [No Abstract] [Full Text] [Related]
15. Prostatic specific antigen in prostate cancer. Morote J; Ruibal A Int J Biol Markers; 1987; 2(2):133. PubMed ID: 2454273 [No Abstract] [Full Text] [Related]
16. Prostate-specific membrane antigen expression in the duodenum: implications in coeliac disease and immunotherapy for prostate cancer. Maraj BH; Aldersley MA; Markham AF Lancet; 1998 May; 351(9115):1559-60. PubMed ID: 10326547 [No Abstract] [Full Text] [Related]
17. [Specific antigens in screening and monitoring patients with prostate cancer]. Grigor'ev ME; Stepenskiĭ AB; Lebedev DV Urologiia; 2002; (2):50-4. PubMed ID: 12077825 [No Abstract] [Full Text] [Related]
18. Immunology of prostatic carcinoma-an overview. Frost P; Rose NR; Choe BK Semin Oncol; 1976 Jun; 3(2):107-13. PubMed ID: 935881 [TBL] [Abstract][Full Text] [Related]
19. Papillary cystoadenocarcinoma of the prostate. Takeuchi S; Higashi Y; Kobayashi I; Takahama M Hinyokika Kiyo; 1992 Mar; 38(3):347-9. PubMed ID: 1381865 [TBL] [Abstract][Full Text] [Related]
20. Circulating antibody to prostate antigen in patients with prostate cancer. Chu TM; Kuriyama M; Johnson E; Papsidero LD; Killian CS; Murphy GP; Wang MC Transplant Proc; 1984 Apr; 16(2):481-5. PubMed ID: 6202027 [No Abstract] [Full Text] [Related] [Next] [New Search]